Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Abcellera Biologics Inc
(NQ:
ABCL
)
2.610
+0.100 (+3.98%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Abcellera Biologics Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
AbCellera to Report First Quarter 2024 Financial Results on May 7, 2024
April 03, 2024
From
AbCellera Biologics Inc.
Via
Business Wire
The 7 Best Penny Stocks to Buy in Q2 2024
March 27, 2024
Discover seven penny stocks to buy primed for significant gains in Q2 2024. Don't miss out on these picks or your portfolio could suffer.
Via
InvestorPlace
AbCellera to Present at the Bloom Burton Healthcare Conference on April 16, 2024
March 19, 2024
From
AbCellera Biologics Inc.
Via
Business Wire
AbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological Conditions
March 11, 2024
From
AbCellera Biologics Inc.
Via
Business Wire
Recap: AbCellera Biologics Q4 Earnings
February 20, 2024
Via
Benzinga
Recap: These 7 Artificial Intelligence (AI) Stock Categories Had Returns From +2 To +15% In February
March 06, 2024
This article is a recap of how 7 artificial intelligence stock categories did in February, and YTD, compared to each other to help you make prudent investment decisions accordingly.
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
AbCellera Announces Four Presentations on T-Cell Engagers at AACR 2024
March 05, 2024
From
AbCellera Biologics Inc.
Via
Business Wire
AI-Powered Drug Discovery Stocks Index Up 9% In February; Remains Down 8% YTD
March 04, 2024
Grand View Research says the global
Via
Talk Markets
3 Highly Rated Biotech Stocks to Buy for 300% Gains
February 26, 2024
Biotech stocks like those discussed here have the potential to produce 300% returns and benefit from high analyst ratings.
Via
InvestorPlace
AbCellera Announces Resignation of Board Member
February 23, 2024
From
AbCellera Biologics Inc.
Via
Business Wire
AbCellera to Present at Upcoming Investor Conferences in March
February 22, 2024
From
AbCellera Biologics Inc.
Via
Business Wire
AbCellera Biologics (ABCL) Q4 2023 Earnings Call Transcript
February 20, 2024
ABCL earnings call for the period ending December 31, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
AbCellera Reports Full Year 2023 Business Results
February 20, 2024
From
AbCellera Biologics Inc.
Via
Business Wire
Earnings Scheduled For February 20, 2024
February 20, 2024
Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at $0.36 per share on revenue of $7.38 billion.
Via
Benzinga
These 9 AI Stock Categories Performed From +18% To -4% Last Week
February 19, 2024
A synopsis of the performances of each of the 9 different artificial intelligence stock categories last week, and YTD, along with a description of what makes up each category and the stocks included in...
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
AI-Powered Drug Discovery Stocks Index Up 18% Last Week, Led By BioXcel Therapeutics
February 19, 2024
The AI-powered drug discovery market is projected to grow at a 30% CAGR between now and 2030, with annual sales in excess of $50 billion anticipated. An AI drug discovery revolution is underway.
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
AbCellera to Report Full Year 2023 Financial Results on February 20, 2024
January 23, 2024
From
AbCellera Biologics Inc.
Via
Business Wire
4 Magnificent Healthcare Stocks to Buy in 2024 and Beyond
January 16, 2024
Healthcare stocks have underperformed in 2023, but that is expected to change this year.
Via
The Motley Fool
3 Growth Stocks That Could Go Parabolic in 2024
January 15, 2024
These innovation-oriented companies could take flight this year.
Via
The Motley Fool
AI-Focused Drug Discovery Stocks Index Up 26% In December
December 29, 2023
With the promise of lower costs and shorter development timelines, AI-enabled drug discovery holds massive potential to increase the accessibility of drugs and to treat presently incurable conditions.
Via
Talk Markets
AbCellera to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024
December 20, 2023
From
AbCellera Biologics Inc.
Via
Business Wire
AI-Focused Drug Discovery Stocks Index Up 10.6% Last Week
December 17, 2023
A new study concludes that the AI method of drug discovery is up to 250 times more efficient than the traditional method.
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
AI Meets Biotech: 3 Top Stocks Transforming Medical Science
December 16, 2023
The AI revolution is bringing big gains to biotechnology, including drugs, antibodies, and synthetic biology.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
The 10 Stocks Using AI To Develop New Drugs Were Up 4%, On Average, Last Week
December 11, 2023
If, as Morgan Stanley postulates, a $50 billion AI drug discovery revolution is underway, here are 10 publicly-traded micro- and small-cap clinical stage pharma companies that are embracing AI to...
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Micro/Small Cap Companies Using AI In Drug Discovery Up 35% In November
December 06, 2023
The AI method is up to 250 times more efficient than the traditional method of drug discovery. reducing timelines for drug discovery, increasing accuracy of efficacy and safety predictions.
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
AbCellera to Present at the Piper Sandler 35th Annual Healthcare Conference on November 30, 2023
November 16, 2023
From
AbCellera Biologics Inc.
Via
Business Wire
AbCellera Presents New Data on Two T-Cell Engager Programs at SITC 2023
November 03, 2023
From
AbCellera Biologics Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
November 03, 2023
Via
Benzinga
AbCellera Biologics (ABCL) Q3 2023 Earnings Call Transcript
November 03, 2023
ABCL earnings call for the period ending September 30, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
12 Health Care Stocks Moving In Thursday's After-Market Session
November 02, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.